RECRUITING

AvertD Post-Approval Study

Description

A Prospective Post-Approval Study of AvertD to Evaluate Device Performance, Prescribing Impact, and Labeling Comprehension in the Intended Use Population

Conditions

Opioid Use Disorder
Talk to us

Related Conditions:

Opioid Use Disorder

Study Overview

On this page

Study Details

Study overview

A Prospective Post-Approval Study of AvertD to Evaluate Device Performance, Prescribing Impact, and Labeling Comprehension in the Intended Use Population

AvertD Post-Approval Study

AvertD Post-Approval Study

Condition
Opioid Use Disorder
Intervention / Treatment

-

Contacts and Locations

Indianapolis

Concentrics Research, Indianapolis, Indiana, United States, 46240

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * ≥18 years of age
  • * Prior to first opioid prescription
  • * Being considered for first oral opioid prescription (4-30 days)
  • * Prescribed AvertD as part of care
  • * Willing and able to complete yearly assessments for 5 years
  • * Signed informed consent
  • * Planned opioid prescription \<4 or \>30 days
  • * Any condition making participation unsafe or infeasible per investigator judgment

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

Prescient Medicine Holdings, Inc.,

Study Record Dates

2031-11